Delivery Order 75N93021D00031-75N93022F00001
Award Date
9/26/22
Potential Completion Date
12/1/23
Potential Value
$716K
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20852, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $2,000 firm fixed price delivery order against an unspecified contract vehicle to Lovelace Biomedical Research Institute. The delivery order is for comprehensive and rapid response services to support NIAID's research programs over a one year period from September 2021 through August 2022. The place of performance will be in Bethesda, Maryland. No set aside designation or subcontractors were...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $20,168 delivery order to Lovelace Biomedical Research Institute under the Resources to Advance Pediatrics and HIV Prevention Science indefinite-delivery/indefinite-quantity master contract. Lovelace will perform guaranteed minimum work related to advancing pediatrics and HIV prevention science from April 2023 through June 2024 in Albuquerque, New Mexico. The...
The Lovelace Biomedical Research Institute was awarded a $18,397 cost plus fixed fee delivery order against the Preclinical Services for HIV Therapeutics master indefinite-delivery/indefinite-quantity contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The purpose of this task order is for Lovelace to develop and deliver a quality assurance/quality control plan and participate in a task order initiation meeting to support preclinical services...
This is a federal contract award issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a subsidiary of Lovelace Biomedical Research Institute. The $1,013,722.26 award is for Task Order 6, Task Area B under the GTRP Pharmacology-Toxicology Core Lab contract. The work will be performed in Albuquerque, NM and the period of performance runs through April 15,...
This delivery order against the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases' Preclinical Services for HIV Therapeutics master IDIQ contract funds the guaranteed minimum amount of $0.00 to Lovelace Biomedical and Environmental Research Institute, Inc. for preclinical services supporting HIV therapeutics research. Performance will occur in Albuquerque, New Mexico. The prime contractor, Lovelace Biomedical and...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The $481,814.66 contract is for the transfer and validation of a bioanalytical method to detect cabotegravir, a candidate HIV treatment, in rat plasma. This work is being conducted under NIAID's Comprehensive Resources for HIV...
This is a federal delivery order contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The contract, valued at $57,500.00, is for IDIQ contract management support activities related to the BIO-AMT-2301 program. This appears to be an unset-aside contract. Lovelace Biomedical Research Institute has extensive experience supporting...
This is a $4,711,752.76 cost-plus-fixed-fee delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to the Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The order is part of the Biomedical Advanced Research and Development Authority's (BARDA) Biological Animal Model Development 2017-2022 contract vehicle and involves the development of animal models for evaluating medical countermeasures against...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $2,645,425.63 definitive contract to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI) to conduct the "Natural History of Andenovirus and Related Disease in Immuncomporised Pediatric Patients" project. This contract, which does not have a set-aside designation, was issued under LBERI's parent company Lovelace Biomedical Research Institute, an expert in preclinical research services across...
This is a cost-plus-fixed-fee delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Lovelace Biomedical Research Institute, a non-profit preclinical contract research organization. The $756,111 award supports non-clinical immunogenicity studies of SARS-CoV-2 microneedle patch vaccine candidates in a small-animal model. This work is being performed under ASPR's Biological Animal Model Development 2017-2022 IDIQ contract. Lovelace Biomedical...